Effects of methylphenidate on appetite and growth in children diagnosed with attention deficit and hyperactivity disorder

References

1. Arora S, Anubhuti. Role of neuropeptides in appetite regulation and obesity–a review. Neuropeptides 2006;40:375–401.10.1016/j.npep.2006.07.001Suche in Google Scholar PubMed

2. Keen-Rhinehart E, Ondek K, Schneidr JE. Neuroendocrine regulation of appetitive ingestive behavior. Front Neurosci 2013;7:213.10.3389/fnins.2013.00213Suche in Google Scholar PubMed PubMed Central

3. Sobrino Crespo C, Perianes Cachero A, Puebla Jiménez L, Barrios V, Arilla Ferreiro E. Peptides and food intake. Front Endocrinol (Lausanne) 2014;5:58.10.3389/fendo.2014.00058Suche in Google Scholar PubMed PubMed Central

4. Anık A, Çatlı G, Abacı A, Küme T, Bober E. Fasting and postprandial levels of a novel anorexigenic peptide nesfatin in childhood obesity. J Pediatr Endocrinol Metab 2014;27:623–8.10.1515/jpem-2013-0475Suche in Google Scholar PubMed

5. Vehapoglu A, Ustabas F, Ozgen TI, Terzioglu S, Cermik BB, et al. Role of circulating adipocytokines vaspin, apelin, and visfatin in the loss of appetite in underweight children: a pilot trial. J Pediatr Endocrinol Metab 2015;28:1065–71.10.1515/jpem-2014-0490Suche in Google Scholar PubMed

6. Kitahara CM, Trabert B, Katki HA, Chaturvedi AK, Kemp TJ, et al. Body mass index, physical activity, and serum markers of inflammation, immunity, and insulin resistance. Cancer Epidemiol Biomarkers Prev 2014;23:2840–9.10.1158/1055-9965.EPI-14-0699-TSuche in Google Scholar PubMed PubMed Central

7. Olama SM, Elsaid TO, El-Arman M. Serum leptin in Egyptian patients with fibromyalgia syndrome: relation to disease severity. Int J Rheum Dis 2013;16:583–9.10.1111/1756-185X.12155Suche in Google Scholar PubMed

8. Wang Y, Shen Y, Zuo Q, Zhao L, Wan C, et al. Evaluation of ghrelin level and appetite regulation in patients with acute exacerbations of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2014;9:863–70.Suche in Google Scholar

9. Kanat BH, Ayten R, Aydın S, Girgin M, Cetinkaya Z, et al. Significance of appetite hormone ghrelin and obestatin levels in the assessment of the severity of acute pancreatitis. Turk J Gastroenterol 2014;25:309–13.10.5152/tjg.2014.4081Suche in Google Scholar PubMed

10. Zabarovskaja S, Freda P, Williams JJ, Kunavarapu C, Lamanca J, et al. Acylation of ghrelin is increased in heart failure and decreases post heart transplantation. Scand Cardiovasc J 2014;48:343–8.10.3109/14017431.2014.955052Suche in Google Scholar PubMed PubMed Central

11. Naufel MF, Bordon M, de Aquino TM, Ribeiro EB, de Abreu Carvalhaes JT. Plasma levels of acylated and total ghrelin in pediatric patients with chronic kidney disease. Pediatr Nephrol 2010;25:2477–82.10.1007/s00467-010-1628-5Suche in Google Scholar PubMed

12. Baratta M. Leptin–from a signal of adiposity to a hormonal mediator in peripheral tissues. Med Sci Monit 2002;8:282–92.Suche in Google Scholar

13. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998;395:763–70.10.1038/27376Suche in Google Scholar PubMed

14. Wauters M, Considine RV, Van Gaal LF. Human leptin: from an adipocyte hormone to an endocrine mediator. Eur J Endocrinol 2000;143:293–311.10.1530/eje.0.1430293Suche in Google Scholar PubMed

15. Webber J. Energy balance in obesity. Proc Nutr Soc 2003;62:539–43.10.1079/PNS2003256Suche in Google Scholar PubMed

16. Harvey J. Leptin regulation of neuronal morphology and hippocampal synaptic function. Front Synaptic Neurosci 2013;5:3.10.3389/fnsyn.2013.00003Suche in Google Scholar PubMed PubMed Central

17. Büyükgebiz B, Oztürk Y, Yilmaz S, Arslan N. Serum leptin concentrations in children with mild protein-energy malnutrition and catch-up growth. Pediatr Int 2004;46:534–538.10.1111/j.1442-200x.2004.01951.xSuche in Google Scholar PubMed

18. Trayhurn P, Hoggard N, Mercer JG, Rayner DV. Leptin: fundamental aspects. Int J Obes Relat Metab Disord 1999;23:22–28.10.1038/sj.ijo.0800791Suche in Google Scholar PubMed

19. Salman N, Ozturk G, Akin I, Kilicaslan S, Demirel F, et al. The effect of adenotonsilectomy on ghrelin, leptin, IGF-1 levels and growth parameters in children with adenotonsillar hypertrophy. J Pediatr Endocrinol Metab 2014;27:885–90.10.1515/jpem-2013-0367Suche in Google Scholar PubMed

20. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402:656–60.10.1038/45230Suche in Google Scholar PubMed

21. Korbonits M, Goldstone AP, Gueorguiev M, Grossman AB. Ghrelin–a hormone with multiple functions. Front Neuroendocrinol 2004;25:27–68.10.1016/j.yfrne.2004.03.002Suche in Google Scholar PubMed

22. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, et al. A role for ghrelin in the central regulation of feeding. Nature 2001;409:194–8.10.1038/35051587Suche in Google Scholar PubMed

23. Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001;86:4753–8.10.1210/jcem.86.10.7885Suche in Google Scholar PubMed

24. Toshinai K, Date Y, Murakami N, Shimada M, Mondal MS, et al. Ghrelin-induced food intake is mediated via the orexin pathway. Endocrinology 2003;144:1506–12.10.1210/en.2002-220788Suche in Google Scholar PubMed

25. Oh-I S, Shimizu H, Satoh T, Okada S, Adachi S, et al. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006;443:709–12.10.1038/nature05162Suche in Google Scholar PubMed

26. Shimizu H, Oh-I S, Hashimoto K, Nakata M, Yamamoto S, et al. Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. Endocrinology 2009;150:662–71.10.1210/en.2008-0598Suche in Google Scholar PubMed

27. Shimizu H, Oh-I S, Okada S, Mori M. Nesfatin-1: an overview and future clinical application. Endocr J 2009;56:537–43.10.1507/endocrj.K09E-117Suche in Google Scholar

28. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorder, 4th ed. Washington, DC, American Psychiatric Association, 1994, 55–85.Suche in Google Scholar

29. Didoni A, Sequi M, Panei P, Bonati M; Lombardy ADHD Registry Group. One-year prospective follow-up of pharmacological treatment in children with attention-deficit/hyperactivity disorder. Eur J Clin Pharmacol 2011;67:1061–7.10.1007/s00228-011-1050-3Suche in Google Scholar PubMed

30. Mannuzza S, Klein RG, Bonagura N, Malloy P, Giampino TL, et al. Hyperactive boys almost grown up. V. Replication of psychiatric status. Arch Gen Psychiatry 1991;48:77–83.10.1001/archpsyc.1991.01810250079012Suche in Google Scholar PubMed

31. Günther T, Kahraman-Lanzerath B, Knospe EL, Herpertz-Dahlmann B, Konrad K. Modulation of attention-deficit/hyperactivity disorder symptoms by short- and long-acting methylphenidate over the course of a day. J Child Adolesc Psychopharmacol 2012;22:131–8.10.1089/cap.2010.0146Suche in Google Scholar PubMed

32. Swanson JM, Wigal SB, Wigal T, Sonuga-Barke E, Greenhill LL, et al. A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study). Pediatrics 2004;113:206–16.10.1542/peds.113.3.e206Suche in Google Scholar PubMed

33. Brams M, Mao AR, Doyle RL. Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder. Postgrad Med 2008;120:69–88.10.3810/pgm.2008.09.1909Suche in Google Scholar PubMed

34. Aagaard L, Hansen EH. Adverse drug reaction labelling for atomoxetine, methylphenidate and modafinil: comparison of product information for oral formulations in Australia, Denmark and the United States. Curr Drug Saf 2013;8:162–8.10.2174/15748863113089990042Suche in Google Scholar

35. Lee MS, Lee SI, Hong SD, Kim JH, Choi J, et al. Two different solicitation methods for obtaining information on adverse events associated with methylphenidate in adolescents: a 12-week multicenter, open-label study. J Child Adolesc Psychopharmacol 2013;23:22–7.10.1089/cap.2012.0018Suche in Google Scholar PubMed

36. Findling RL, Wigal SB, Bukstein OG, Boellner SW, Abikoff HB, et al. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials. Clin Ther 2009;31: 1844–55.10.1016/j.clinthera.2009.08.002Suche in Google Scholar PubMed

37. Lee J, Grizenko N, Bhat V, Sengupta S, Polotskaia A, et al. Relation between therapeutic response and side effects induced by methylphenidate as observed by parents and teachers of children with ADHD. BMC Psychiatry 2011;11:70.10.1186/1471-244X-11-70Suche in Google Scholar PubMed PubMed Central

38. Neyzi O, Saka HN, Kurtoğlu S. Anthropometric studies on the Turkish population--a historical review. J Clin Res Pediatr Endocrinol 2013;5:1–12.10.4274/Jcrpe.957Suche in Google Scholar PubMed PubMed Central

39. Grimberg A, Lifshitz F. Worrisome Growth. In: Lifshitz F, editor. Pediatric Endocrinology.5th ed. New York: Informa Healthcare, 2007:1–50.Suche in Google Scholar

40. Steele M, Weiss M, Swanson J, Wang J, Prinzo RS, et al. A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder. Can J Clin Pharmacol 2006;13:50–62.Suche in Google Scholar

41. McGough JJ, McBurnett K, Bukstein O, Wilens TE, Greenhill L, et al. Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2006;16:351–6.10.1089/cap.2006.16.351Suche in Google Scholar PubMed

42. Işeri E, Kiliç BG, Senol S, Karabacak NI. Effects of methylphenidate on leptin and appetite in children with attention-deficit hyperactivity disorder: an open label trial. Methods Find Exp Clin Pharmacol 2007;29:47–52.10.1358/mf.2007.29.1.1063491Suche in Google Scholar PubMed

43. Methylphenidate: growth retardation. Prescrire Int 2011;20:238–9.Suche in Google Scholar

44. Zhang H, Du M, Zhuang S. Impact of long-term treatment of methylphenidate on height and weight of school age children with ADHD. Neuropediatrics 2010;41:55–9.10.1055/s-0030-1261893Suche in Google Scholar PubMed

45. Lisska MC, Rivkees SA. Daily methylphenidate use slows the growth of children: a community based study. J Pediatr Endocrinol Metab 2003;16:711–8.Suche in Google Scholar